BRD2 and Alzheimer disease: Herein, we took a translational approach to examine whether increasing FSH and LH from premenopausal to postmenopausal levels were associated with biomarker evidence of AD risk, as reflected in higher Aβ deposition and lower GMV (a marker of neuronal loss) in AD-vulnerable regions of midlife women at risk for AD.